IQV - IQVIA Holdings Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (-0.77%) SPX (-0.77%) TVIX (4.67%) ZS (-1.4%) SPLK (0.93%) RKDA (-8.87%) QQQ (-0.78%) PG (-1.12%) PFE (-1.62%) PANW (0.84%) NVS (-0.45%) MSFT (-0.84%) MRK (-0.63%) MCD (-0.15%) JMIA (-4.29%) IWM (-0.66%) GOOGL (-1.41%) GE (-3.35%) FB (-1.27%) ETHUSD (%) EKSO (-2.44%) DIS (-0.12%) CVX (-1.01%) BTCUSD (%) BBY (-0.34%)

IQVIA Launches Patient Portal to Transfo...	08/15/19
IQVIA™ (IQV) announces its launch of the IQVIA Patient Portal, a global web-based solution built on a leading health cloud platform. This innovative ...

3 Top Biotech Stocks to Buy in August	08/14/19
In the high-risk world of biotech investing, there are no guarantees of success. Still, sometimes investors can find places where the odds look reason...

IQVIA Holdings (NYSE:IQV) Has A Pretty H...	08/14/19
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

IQVIA Announces Repurchase of Common Sto...	08/08/19
IQVIA Holdings Inc. today announced that it has agreed to purchase an aggregate of 1,000,000 shares of its common stock in a private transaction from ...

3 Keys to Investing in Next-Gen Healthca...	08/06/19
Picture a bizarre clothing store for a moment …Source: Shutterstock You walk in. An employee sizes you up and asks you if there's anything in part...

IQVIA Named Real World Evidence Leader	08/05/19
Biopharma companies pick IQVIA as the leader in real world data and evidence services in new Life Science Strategy Group report

IQVIA’s Cynthia Verst Honored on 2019 Ph...	08/01/19
IQVIA™ today announced that Cynthia Verst, IQVIA’s president, Design and Delivery Innovation, Research & Development Solutions, has been named to Phar...

Buy rating	06/21/19
Mizuho upgrades from Neutral to Buy rating and raises Price Target from $150.00 to $175.00

Buy rating	06/19/19
Stifel Nicolaus maintains Buy rating and raises Price Target from $167.00 to $178.00

Strong Buy rating	06/19/19
Morgan Stanley maintains Overweight rating and raises Price Target from $156.00 to $170.00

Hold rating	06/19/19
Mizuho maintains Neutral rating and raises Price Target from $145.00 to $150.00

Strong Buy rating	05/28/19
SVB Leerink initiates coverage with Outperform rating and announces Price Target of $160.00

Strong Buy rating	03/18/19
Barclays maintains Overweight rating and raises Price Target from $160.00 to $167.00

Buy rating	02/25/19
Argus maintains Buy rating and raises Price Target from $140.00 to $160.00

HOLDERS

% Insider	12.52%	% Institutional	76.43%

Top 10 Institutional Owners

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%

Previous Close	$156.72	Open	$156.92
Volume	585.2K	Market Cap	26.85B
Yield		Last Dividend

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

Service Name	Trader	% Success
Jess Corner	Jess	81.00 %	Follow
Option short-term trading [Unusual]	Debashis K	73.00 %	Subscribe

IQV - IQVIA Holdings

$154.82 -1.9[-1.22%]

Add to New List:

Day

52 Week

ANALYST RATINGS

85.71 %

Price Target (PT)

EARNINGS

FINANCE

HOLDERS

Top 10 Institutional Owners

TRADERS TRACKING $IQV

About Us

Product Types

Strategies

Follow Us

Secure Payments